Payment overview · 2025
General Payments
$14.63
1 reported records · 1 companies
Healthcare provider profile · identity verified
Suraj K Tikko, MD
Allopathic & Osteopathic Physicians|Internal Medicine · NEW YORK, NY · NPI 1306947957
Verified facts
What the public records show
CMS Open Payments records show Suraj K Tikko, MD received $14.63 in general payments during 2025 across 1 reported records.
Otsuka America Pharmaceutical, Inc. accounted for 100.0% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 1 associated product.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| Otsuka America Pharmaceutical, Inc. | Unresolved — no canonical attribution shown | $14.63 | 100.0% | 1 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Education | $14.63 | 1 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| REXULTI Normalized: rexulti |
Drug | Otsuka America Pharmaceutical, Inc. | $14.63 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
No exact normalized or approved-alias overlap was found in the loaded Part D year. This does not mean the doctor never prescribed the product.
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
No publishable same-company prescribing overlap was found in the loaded Part D year. This does not mean the doctor never prescribed a drug reported elsewhere by a paying company.
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Eliquis | Apixaban | 543 | 46 |
| Amlodipine Besylate | Amlodipine Besylate | 472 | 71 |
| Atorvastatin Calcium | Atorvastatin Calcium | 458 | 68 |
| Furosemide | Furosemide | 456 | 59 |
| Levothyroxine Sodium | Levothyroxine Sodium | 428 | 53 |
| Escitalopram Oxalate | Escitalopram Oxalate | 362 | 54 |
| Potassium Chloride | Potassium Chloride | 286 | 39 |
| Quetiapine Fumarate | Quetiapine Fumarate | 251 | 31 |
| Metoprolol Succinate | Metoprolol Succinate | 249 | 44 |
| Mirtazapine | Mirtazapine | 244 | 36 |
| Gabapentin | Gabapentin | 209 | 32 |
| Metoprolol Tartrate | Metoprolol Tartrate | 191 | 32 |
| Tamsulosin Hcl | Tamsulosin Hcl | 191 | 31 |
| Pantoprazole Sodium | Pantoprazole Sodium | 184 | 26 |
| Omeprazole | Omeprazole | 168 | 33 |
| Losartan Potassium | Losartan Potassium | 161 | 28 |
| Sertraline Hcl | Sertraline Hcl | 160 | 19 |
| Divalproex Sodium | Divalproex Sodium | 157 | 15 |
| Lisinopril | Lisinopril | 147 | 22 |
| Januvia | Sitagliptin Phosphate | 141 | 12 |
| Famotidine | Famotidine | 130 | 23 |
| Metformin Hcl | Metformin Hcl | 116 | 22 |
| Trazodone Hcl | Trazodone Hcl | 111 | 18 |
| Spironolactone | Spironolactone | 105 | 11 |
| Simvastatin | Simvastatin | 96 | 16 |
| Donepezil Hcl | Donepezil Hcl | 92 | 15 |
| Entresto | Sacubitril/Valsartan | 92 | suppressed |
| Memantine Hcl | Memantine Hcl | 88 | 13 |
| Clopidogrel | Clopidogrel Bisulfate | 86 | 11 |
| Citalopram Hbr | Citalopram Hydrobromide | 79 | 12 |
| Levetiracetam | Levetiracetam | 79 | suppressed |
| Santyl | Collagenase Clostridium Hist. | 79 | 28 |
| Mupirocin | Mupirocin | 69 | 34 |
| Carvedilol | Carvedilol | 68 | suppressed |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 68 | suppressed |
| Humalog Kwikpen U-100 | Insulin Lispro | 66 | suppressed |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 65 | 17 |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 61 | suppressed |
| Warfarin Sodium | Warfarin Sodium | 60 | suppressed |
| Hydralazine Hcl | Hydralazine Hcl | 59 | suppressed |
| Hydrochlorothiazide | Hydrochlorothiazide | 53 | suppressed |
| Methenamine Hippurate | Methenamine Hippurate | 52 | suppressed |
| Oseltamivir Phosphate | Oseltamivir Phosphate | 51 | 49 |
| Jardiance | Empagliflozin | 50 | suppressed |
| Olanzapine | Olanzapine | 50 | suppressed |
| Duloxetine Hcl | Duloxetine Hcl | 48 | suppressed |
| Prednisone | Prednisone | 48 | 19 |
| Risperidone | Risperidone | 48 | suppressed |
| Atenolol | Atenolol | 45 | suppressed |
| Ipratropium-Albuterol | Ipratropium/Albuterol Sulfate | 45 | suppressed |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 45 | suppressed |
| Buspirone Hcl | Buspirone Hcl | 43 | suppressed |
| Clonazepam | Clonazepam | 43 | suppressed |
| Tradjenta | Linagliptin | 43 | suppressed |
| Trelegy Ellipta | Fluticasone/Umeclidin/Vilanter | 43 | suppressed |
| Cephalexin | Cephalexin | 40 | 24 |
| Finasteride | Finasteride | 40 | suppressed |
| Montelukast Sodium | Montelukast Sodium | 40 | suppressed |
| Nystatin | Nystatin | 40 | 22 |
| Azithromycin | Azithromycin | 38 | 24 |
| Bupropion Hcl | Bupropion Hcl | 38 | suppressed |
| Diltiazem 24hr Er | Diltiazem Hcl | 38 | suppressed |
| Galantamine Er | Galantamine Hbr | 38 | suppressed |
| Lovastatin | Lovastatin | 37 | suppressed |
| Memantine Hcl Er | Memantine Hcl | 37 | suppressed |
| Latanoprost | Latanoprost | 36 | suppressed |
| Timolol Maleate | Timolol Maleate | 36 | suppressed |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 36 | 17 |
| Baclofen | Baclofen | 35 | suppressed |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 35 | suppressed |
| Roflumilast | Roflumilast | 35 | suppressed |
| Diltiazem 24hr Er (La) | Diltiazem Hcl | 34 | suppressed |
| Silver Sulfadiazine | Silver Sulfadiazine | 34 | 16 |
| Enulose | Lactulose | 33 | 14 |
| Trulicity | Dulaglutide | 31 | suppressed |
| Enalapril Maleate | Enalapril Maleate | 30 | suppressed |
| Ciprofloxacin Hcl | Ciprofloxacin Hcl | 29 | 14 |
| Doxycycline Hyclate | Doxycycline Hyclate | 28 | 19 |
| Fluoxetine Hcl | Fluoxetine Hcl | 28 | suppressed |
| Ketoconazole | Ketoconazole | 28 | 13 |
| Lorazepam | Lorazepam | 28 | suppressed |
| Methimazole | Methimazole | 28 | suppressed |
| Clonidine Hcl | Clonidine Hcl | 26 | suppressed |
| Clozapine | Clozapine | 26 | suppressed |
| Colchicine | Colchicine | 26 | suppressed |
| Nuplazid | Pimavanserin Tartrate | 26 | suppressed |
| Fenofibrate | Fenofibrate Nanocrystallized | 24 | suppressed |
| Tramadol Hcl | Tramadol Hcl | 24 | suppressed |
| Triamterene-Hydrochlorothiazid | Triamterene/Hydrochlorothiazid | 24 | suppressed |
| Vitamin D2 | Ergocalciferol (Vitamin D2) | 24 | suppressed |
| Allopurinol | Allopurinol | 23 | suppressed |
| Autoshield Duo Pen Needle | Pen Needle,dual Safety,diabetc | 23 | suppressed |
| Folic Acid | Folic Acid | 23 | suppressed |
| Pravastatin Sodium | Pravastatin Sodium | 23 | suppressed |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 22 | 19 |
| Carbidopa-Levodopa | Carbidopa/Levodopa | 22 | suppressed |
| Alprazolam | Alprazolam | 21 | suppressed |
| Amiodarone Hcl | Amiodarone Hcl | 21 | suppressed |
| Carbidopa-Levodopa Er | Carbidopa/Levodopa | 21 | suppressed |
| Fenofibrate | Fenofibrate | 21 | suppressed |
| Labetalol Hcl | Labetalol Hcl | 21 | suppressed |
| Letrozole | Letrozole | 21 | suppressed |
| Ramipril | Ramipril | 21 | suppressed |
| Dextrose 5%-0.45% Nacl | Dextrose 5 %-0.45 % Sod Chlord | 20 | 13 |
| Hydrocortisone | Hydrocortisone | 20 | 11 |
| Scopolamine | Scopolamine | 20 | suppressed |
| Esomeprazole Magnesium | Esomeprazole Magnesium | 19 | suppressed |
| Lactulose | Lactulose | 19 | suppressed |
| Lisinopril-Hydrochlorothiazide | Lisinopril/Hydrochlorothiazide | 19 | suppressed |
| Rytary | Carbidopa/Levodopa | 19 | suppressed |
| Ceftriaxone | Ceftriaxone Sodium | 18 | suppressed |
| Digoxin | Digoxin | 18 | suppressed |
| Lantus | Insulin Glargine,hum.Rec.Anlog | 18 | suppressed |
| Restasis | Cyclosporine | 18 | suppressed |
| Glipizide Er | Glipizide | 17 | suppressed |
| Metformin Hcl Er | Metformin Hcl | 17 | suppressed |
| Metronidazole | Metronidazole | 17 | suppressed |
| Admelog | Insulin Lispro | 16 | suppressed |
| Arexvy | Rsvpref3 Antigen/As01e/Pf | 16 | 16 |
| Clindamycin Hcl | Clindamycin Hcl | 16 | suppressed |
| Admelog Solostar | Insulin Lispro | 15 | suppressed |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 15 | suppressed |
| Humulin 70/30 Kwikpen | Insulin Nph Hum/Reg Insulin Hm | 15 | suppressed |
| Hydroxyurea | Hydroxyurea | 15 | suppressed |
| Levofloxacin | Levofloxacin | 15 | 12 |
| Methotrexate | Methotrexate Sodium | 15 | suppressed |
| Myrbetriq | Mirabegron | 15 | suppressed |
| Nifedipine Er | Nifedipine | 15 | suppressed |
| Ondansetron Hcl | Ondansetron Hcl | 15 | suppressed |
| Xarelto | Rivaroxaban | 15 | suppressed |
| Diclofenac Sodium | Diclofenac Sodium | 14 | suppressed |
| Breo Ellipta | Fluticasone/Vilanterol | 13 | suppressed |
| Brimonidine Tartrate | Brimonidine Tartrate | 13 | suppressed |
| Bupropion Hcl Sr | Bupropion Hcl | 13 | suppressed |
| Cefuroxime | Cefuroxime Axetil | 13 | 12 |
| Clonidine | Clonidine | 13 | suppressed |
| Midodrine Hcl | Midodrine Hcl | 13 | suppressed |
| Ssd | Silver Sulfadiazine | 13 | suppressed |
| Aspirin-Dipyridamole Er | Aspirin/Dipyridamole | 12 | suppressed |
| Bupropion Xl | Bupropion Hcl | 12 | suppressed |
| Dicyclomine Hcl | Dicyclomine Hcl | 12 | suppressed |
| Diltiazem Hcl | Diltiazem Hcl | 12 | suppressed |
| Dipyridamole | Dipyridamole | 12 | suppressed |
| Doxazosin Mesylate | Doxazosin Mesylate | 12 | suppressed |
| Felodipine Er | Felodipine | 12 | suppressed |
| Fluticasone Propionate | Fluticasone Propionate | 12 | suppressed |
| Humulin 70-30 | Insulin Nph Hum/Reg Insulin Hm | 12 | suppressed |
| Nebivolol Hcl | Nebivolol Hcl | 12 | suppressed |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 12 | suppressed |
| Repaglinide | Repaglinide | 12 | suppressed |
| Solifenacin Succinate | Solifenacin Succinate | 12 | suppressed |
| Meropenem | Meropenem | 11 | suppressed |
| Paliperidone Er | Paliperidone | 11 | suppressed |
| Ranolazine Er | Ranolazine | 11 | suppressed |
| Telmisartan | Telmisartan | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $14.63 · 1 records | Otsuka America Pharmaceutical, Inc. | REXULTI | — | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error